Cancer Genomics Conference: New Era for Cancer Prevention January 21-22, 2019 Dubai, UAE

Track 1: Cancer Genomics

                   Oncogenomics also called Cancer genomics is one among the sub-field of genomics that characterizes cancer-associated genes. Cancer is a hereditary disease caused by accumulation of DNA mutations and epigenetic changes leading to unrestricted cell proliferation and neoplasm formation. It emphases on genomic, epigenomic and transcript alterations in cancer. The cancer genomics has a goal to identify new oncogenes or tumor suppressor genes that may offer new insights into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies. The success of targeted cancer therapies such as Gleevec, Herceptin and Avastin elevated the hope for oncogenomics to elucidate new targets for cancer treatment.

Track 2: Organ Specific Cancer

                             Cancer is characterized by uncontrolled cell growth, which is spread to different body parts, that leads to formation of lumps or masses of tissue called tumours. One among the leading causes of death all over the world is Cancer. Based on the location of cancer in the body organ, the Organ Specific Cancers are named. There are different kinds of cancers which effects  different body organs. Some of them are   Brain cancer, Head and Neck Cancer, Breast cancer, Prostate cancer, Lung cancer, Oral cancer, Liver cancer, Gastric cancer, Pancreatic cancer, Kidney (Renal Cell) cancer, Leukemia and many more. The most caused cancer of the head and neck is Oral squamous cell carcinomas (OSCCs), which accounts for over 300,000 new cancer cases worldwide annually. 

Track 3: Breast cancer

                           The cancer that grows from breast tissue is called as Breast cancer.  Signs of breast cancer may comprise a lump in the breast, dimpling of the skin, fluid coming from the nipple, an alteration in breast shape,  or a red scaly patch of skin. In those with distant spread of the disease, there may be swollen lymph nodes, bone pain, shortness of breath, or yellow skin. Risk factors comprises being female,  lack of physical exercise, obesity, hormone replacement therapy during menopause, drinking alcohol,  ionizing radiation, early age at first menstruation, older age,  having children late or not at all, and family history. Counting BRCA1 and BRCA2 among others, about 5–10% of cases are due to genes inherited from a person's parents. Cancers emerging from the ducts are identified as ductal carcinomas, while the lobular carcinomas are  emerging from lobules. And in addition, there are more additional 18 sub-types of breast cancer.

Track 4:  Gynecologic Oncology  

                              Gynecologic Oncology also called Cervical Cancer and it is one of the most common cancers in women worldwide. This cancer is not so common in the United States and other countries where cervical cancer screening is repetitive. Cervical cancer is mostly caused due to a virus called Human papillomavirus or also predicted as HPV. There are numerous kinds of the HPV virus, but all of HPV does not reason cervical cancer. Certain of them cause genital warts, but other types may not display any Cervical Cancer signs and symptoms . An infection can go away on its own. But occasionally it can cause genital warts or can also central to cervical cancer, it's significant for women to have regular Pap tests.

Track 5: Pediatric Oncology

                           Pediatric cancer is also called as Childhood cancer which is cancer in a child. In the United States, an subjectively adopted standard of the ages used are 0–14 years wide-ranging, that is, up to 14 years 11.9 months of age. However, in some cases the meaning of childhood cancer comprises adolescents between 15–19 years old. Pediatric oncology is the branch of medicine concerned with the diagnosis and cure of cancer in children. In the Universe, it is assessed that pediatric cancer has an incidence of more than 175,000 per year, and a mortality rate of approximately 96,000 per year. In the urbanized countries, pediatric cancer has a mortality rate of nearly 20% of cases. In low resource settings, on the other hand, mortality is nearly 80%, or even 90% in the world's poorest countries. 

Track 6: Neuro-oncology

                               A brain tumor occurs when unusual cells form within the brain. Malignant or cancerous tumors and benign tumors are the two main types of tumors. Cancerous tumors can be distributed into primary tumors which starts within the brain, and the secondary tumors which are spread from anywhere else, identified as brain metastasis tumors. All sorts of brain tumors may produce symptoms that differ depending on the brain part involved. These symptoms may comprise problem with vision,  vomiting, headaches, seizures, and mental changes. The headache is characteristically worse in the morning and drives away with vomiting. More particular problems may include difficulty in walking, speaking, and with sensation. As the disease advances unconsciousness may occur. 

Track 7: Hematologic Oncology

                          Hematologic Oncology is the branch of medicine deals with the diagnosis, prevention, treatment of disease identified with blood. Hematology includes the study of etiologist comprises the treatment of disease that influence the construction of blood and its parts, for example, platelets, hemoglobin, blood proteins, bone marrow, platelets, veins, spleen, and the component of coagulation. The research facility work that goes into the study of blood is much of the time done by a medical technologist or therapeutic lab researcher. There are different disorders that people are influenced by hematology. The different type of blood conditions that are looked at incorporate anemia, hemophilia, general blood clots, bleeding disorders With reverence to related blood diseases, for example, leukemia, myeloma, and lymphoma, these are more serious cases that should be analyzed.

Track 8: Cancer Immunology

                      An antibody that either treats existing malignancy or averts improvement of a growth is called tumor immunization which accounts cancer immunology.  The third and last stage in tumor development is Tumor progression. By expanded development speed and invasiveness of the tumor cells, this stage is arranged. It was investigated by Obeid et al. how inducing immunogenic cancer cell death ought to become a priority of cancer chemotherapy.

                   He gave a reason that, via a ‘bystander effect’, the immune system would be able to play a factor in destroying chemotherapy-resistant cancer cells. However, the depth in the research is still necessary on how the immune response is triggered against dying tumor cells. It is hypothesized by Professionals in the field that ‘necrotic cell death is truly immunogenic whereas apoptotic cell death is poorly immunogenic.

Track 9:  Radiation Oncology

                    Radiation oncology is the medical field concerned with prescribing radiation, and is separate from radiology. Radiation oncology is the use of radiation in medical imaging and diagnosis. Radiation may be recommended by a radiation oncologist with intent to cure ("curative") or for adjuvant therapy. It may also be used as therapeutic treatment (where the therapy has survival benefit and it can be curative) or palliative treatment (where cure is not possible and the aim is for local disease control or symptomatic relief) . It is also mutual to combine radiation therapy with chemotherapy, surgery, hormone therapy,  or some mixture of the four. Radiation therapy treats most common cancer types in some way. Radiation therapy also called Radiotherapy, commonly abbreviated RT, RTx, or XRT, is therapy using ionizing radiation, generally as portion of cancer treatment to control or kill malignant cells and normally delivered by a linear accelerator.

Track 10: Clinical Oncology

                   Clinical Oncology comprises Medical Oncology (MO), Surgical Oncology (SO), Gynecologic Oncology, Hematologic Malignancies. Medical oncology interconnects the results of clinical and experimental study in oncology and haematology, mainly with experimental therapeutics with the field of immunotherapy and chemotherapy. A surgical and non-surgical oncologist specializes in the elimination of the tumours and nearby tissue during an operation. Hematologic malignancies are forms of cancer that begin in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Thus clinical oncology and Cancer Stem Cell is a unique therapeutic approach.

Track 11: Cancer Epidemiology

                   The study of the factors affecting cancer is called as epidemiology of cancer, as a way to infer possible trends and causes. The study of cancer epidemiology uses epidemiological methods in certain population to find what are the cancer  causes and to identify in order to develop improved treatments. Basing on the progress of the disease, Cancer epidemiology is principally concerned with the study of cancer, its causes, detection, and treatment. 7.98 million people died in the year 2010 due to Cancer and Approximately 12.7 million cancers were diagnosed every year.  

                  Increase in the age increases the high risk of cancer. The common childhood cancers are lymphomas   around 14%, leukemia around 34%, and brain tumors around 23%. Cancer epidemiology study must contend with problems of  lead time bias and length time bias. 

Track 12: Cancer Diagnosis : Tools, Technology and Procedures

                  The appearance of signs or symptoms or through screening, the cancers are initially predictable. Neither of these indications to a definitive diagnosis, which entails the examination of a tissue sample by a pathologist. Medical tests are done to reveal the investigations in People with suspected cancer. These commonly include  X-rays, CT scans, blood tests, and endoscopy.

                The tissue diagnosis from the biopsy indicates the type of cell that is proliferating, genetic abnormalities, its histological grade, and other features. Together, this information is useful to assess the prognosis and to pick the best treatment.

Track 13: Cancer Biomarkers

              Biomarkers are limited to measurement of  proteins in the blood or urine. Biomarkers refers to a substance or process that indicates the presence of cancer in the body. There are different  biomarkers used for the prognosis, diagnosis and epidemiology like epigenetic, Genetic,   glycomics, proteomic, and imaging biomarkers. A number of gene and protein based biomarkers have already been used at some point in patient care; including:

• PSA (Prostate Specific Antigen) (Prostate Cancer),
• AFP (Liver Cancer),
• BRCA1 / BRCA2 (Breast/Ovarian Cancer),
• BRAF V600E (Melanoma/Colorectal Cancer),
• CA-125 (Ovarian Cancer), BCR-ABL (Chronic Myeloid Leukemia), 

                     Existing tumors produce mutant proteins which are detected by Selected Reaction Monitoring (SRM) are reported to be the most specific biomarkers for cancers.

Track 14: Stem cell Therapy in cancers

                   Cancer stem cells (CSCs) is the cancer cells found inside tumors  that possess characteristics associated with normal stem cells called which have the capability to give growth to all cell types found in a particular cancer sample. CSCs may generate tumors through the stem cell processes of self-renewal and variation into multiple cell types. Such cells are hypothesized to persevere in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, for improvement of survival and quality of life of cancer patients,  development of specific therapies targeted at CSCs holds hope, particularly for patients with metastatic disease. Mostly based on animal models Existing cancer treatments have been advanced, where therapies able to endorse tumor shrinkage were deemed effective.

Track 15: Anticancer Drugs and surgery

                              Drug collaboration in oncology is of specific importance attributable to the tight healing list and the unchallengeable lethality of anticancer specialists. Besides treating cancer, it is also necessary to  relieve symptoms of the cancer such as pain and side-effects, such as nausea, commonly seen with the several types of treatment. The administration of human papillomavirus and hepatitis B vaccinations is desirable most commonly. Some of the anticancer drugs are Cabazitaxel, Cetuximab, etc. Chemotherapy drug combinations are as such Cisplatin, Crizotinib.

                          Surgery applied to oncology is called Surgical oncology, applied to oncology which includes the surgical management of tumors, mainly cancerous tumours. There are other names of Surgical oncologist as general surgical oncologist, thoracic surgical oncologists, subspecialty of general surgery, gynecologic oncologists experienced  in handling  the cancer patients.

Track 16: Cancer Pharmacology

           Cancer pharmacology referred as Chemotherapy (frequently abbreviated to chemo and sometimes CTX or CTx) is a class of cancer treatment.  Chemotherapy uses one or more anti-cancer drugs (chemotherapeutic agents) as portion of a consistent chemotherapy regimen. In the cancer pharmacology combination of drugs are used to extend life or to decrease symptoms which is palliative chemotherapy. Chemotherapy is one of the major groups of the medical discipline specifically devoted to pharmacotherapy for cancer, which is named medical oncology. To avoid these implications, recently developed treatments (against specific molecular or genetic targets) which constrain growth-promoting signals coming from classic endocrine hormones like primarily estrogens for breast cancer and androgens for prostate cancer, are named hormonal therapies, whereas the reticence of other growth-promoting influences is called as targeted therapy.

Track 17: Screening and prevention of cancer

                           Cancer screening targets to detect cancer before symptoms appear. This may involve urine tests, blood tests,  other tests, or medical imaging. Early detection and subsequent treatment must be considered against any troubles, which are benefits of screening in terms of cancer prevention, The Universal screening, is also known as mass screening or population screening, which includes screening everyone, usually within a specific age group. People with a family history of cancer are known to be at higher risk of developing cancer are identified as Selective screening.

                            Screening can lead to incorrect positive results and following invasive procedures. Screening can also lead to incorrect negative results, where an existing cancer is missed. Controversy arises when it is not clear if the benefits of screening outweigh the risks of the screening procedure itself, and any follow-up diagnostic tests and treatments. 

Track 18: Oncology Nursing

                        An oncology nurse is a specified nurse who cares for the cancer patients. These nurses require progressive certifications and clinical skills in oncology additional than the typical bachelorette nursing program provides. Oncology nursing care can be defined as meeting the various needs of oncology patients during the period of their disease counting appropriate screenings and other preventative practices, symptom management, care to hold as much normal functioning as possible, and supportive measures upon end of life. Nurses must be able to manage the numerous side effects related with cancer and the treatment. Nurses must have widespread knowledge of pharmacological and non-pharmacological nursing intrusions, and when they are appropriate to use.

Track 19: Cancer Therapy-Related Cardiac Dysfunction

                    Humanity from cancer has decreased enormously over the past few decades, in part, through earlier diagnosis and novel treatments. Appropriately, although cancer-free survival has increased, problems from cancer therapy, particularly effects of cardiac function have partial patient outcomes, impacting the overall morbidity and mortality . The National Cancer Institute (NCI) broadly defines cardiotoxicity as “toxicity that affects the heart”, and intends the Common Terminology Criteria for Hostile Events (CTCAE).Ewer and Lippman proposed cardiotoxicity based on the type and range of structural abnormalities and degree of reversibility.Type I is irreversible and dose-related with myocyte injury, whereas type II contains reversibility with cessation of treatment, absence of dose-relationship, and absence of ultrastructural abnormalities

Track 20: Case reports

                    The information of the preventive or therapeutic interventions is given by the case reports of oncology and Cancer Stem Cell , as these generally require stronger evidence. Thus a case report is an enlarged report of all the particulars of a disease or of a disorder usually made for an individual patient regularly logged in the medical field. The demographic profile of the patient suffering from disease is given by case reports, but stereotypically reference any unusual or unique occurrences. In this Cancer based conference, various special cases where treatment was undiscovered or a special case which might lead the understandings into the Oncology research are discussed. Thus clinical oncology and Cancer Stem Cell is a unique therapeutic approach.

Relevant Conferences:  Cancer Genomics Conferences | Oncologists Meeting | Cancer Research Events | Genetic and Epigenetic Conferences     

• International Conference on Biomarkers and Cancer Targets July 16-17, 2018 Dubai, UAE
• 3^rd World Conferences on Breast and Cervical Cancer September 27-28, 2018 , Abu Dhabi, UAE
• 8^th World conference on Women Health and Breast Cancer August 09-10, 2018 Abu Dhabi
• ESMO Africa Cancer Conferences  February 14-16, 2018 Cape town, South Africa
• SASCRO SASMO Cancer Conference Sandton Convention Centre, South Africa 
• Global Summit on Oncology & Cancer  March 12-14, 2018 Singapore
• 2nd International Conferences on Cancer Genetics and Epigenetics May 24-25, 2018 Tokyo, Japan
• 33^rd International Conference on Oncology Nursing and Cancer Care September 17-18, 2018 Tokyo, Japan
• 27^th  International Conferences on Oncology Research & Cancer Stem Cells May 10-12, 2018 Frankfurt, Germany
• 7^th World Congress on Breast Cancer May 10-11, 2018 Frankfurt, Germany
• 14^th International Conference on Surgical Pathology & Cancer Diagnosis May 17-18, 2018 Rome, Italy
• 3^rd Cancer Diagnostics Conferences & Expo September 20-21, 2018 Berlin, Germany
• 28^th Euro Congress on Cancer Science & Therapy August 09-10, 2018 Madrid, Spain
• 7^th World Congress on Breast Cancer & Therapy May 25-26, 2018, New York, USA
• 6^th World Congress on Breast Pathology and Cancer Diagnosis July 25-26, 2018 Vancouver, Canada
• 3^rd International Conferences on Tumor & Cancer Immunology and Immunotherapy September 17-18, 2018 San Diego, California, USA 
• Aortic International Cancer Conference November 7-10, 2017 Kigali, Rwanda, “World cancer conferences 2018” March 19 to 21 Valencia, Spain

Major Associations:

American Association for Cancer Research, American Brain Tumor Association, American Cancer Society, American Society for Radiation Oncology, American Society of Clinical Oncology, European Association for Cancer Research, Association of European Cancer Leagues, European Oncology Nursing Society, European Society for Medical Oncology, European Society of Gynaecological Oncology, European Society of Surgical Oncology, Acoustic Neuroma Association of Australia, Clinical Oncological Society of Australia, Australian Society of Gynaecologic Oncologists, Asian Society of Gynecologic Oncology, Asian Society for Neuro-Oncology, Saudi Cancer Society, Saudi oncology society and Saudi urology association, Saudi Arabia Cancer Organizations and Resources,  Malaysian Oncology Society, Malaysian Society of Paediatric Haematology and Oncology.

Related Associations and Societies

Societies in USA

American Association for Cancer Research, American Brain Tumor Association, American Cancer Society, American Society for Radiation Oncology, American Society of Clinical Oncology, Association of Community Cancer Centers, Acoustic Neuroma Association, American Society of Pediatric Hematology/Oncology, Hematology/Oncology Pharmacy Association.

Societies in Europe

European Association for Cancer Research, Association of European Cancer Leagues, European Oncology Nursing Society, European Society for Medical Oncology, European Society of Gynaecological Oncology, European Society of Surgical Oncology.

Societies in Asia and Pacific

Acoustic Neuroma Association of Australia, Clinical Oncological Society of Australia, Australian Society of Gynaecologic Oncologists, Asian Society of Gynecologic Oncology, Asian Society for Neuro-Oncology.

Societies in Middle East

Saudi Cancer Society, Saudi oncology society and Saudi urology association, Saudi Arabia Cancer Organizations and Resources,  Malaysian Oncology Society, Malaysian Society of Paediatric Haematology and Oncology.

Why it’s in Dubai, UAE

Cancer genomics conference: New era for Cancer prevention 2018 is going to be held in Dubai. Dubai is the largest and most populous city in the United Arab Emirates (UAE). It is located on the southeast coast of the Persian Gulf and is the capital of the Emirate of Dubai, one of the seven emirates that make up the country. Dubai was ranked 44th among the world's best financial cities and the world's 27th richest city in 2012. It is also an international financial center and has been ranked 37th within the top 50 global financial cities and 1st within the Middle East. As indicated by an examination give an account without bounds intensity of urban communities, in 2025, Dubai will have climbed to 23rd place in general in the Index. Public hospitals in Dubai were first built in the late 1950s and continued to grow with public health initiatives. Out of 28 hospitals in Dubai, 6 are public and 22 are private, with 3 more major hospitals scheduled to be built by 2025. Tumor examine is essentially going ahead in Asian nations close to Dubai, so it is a reasonable goal for Oncology and malignancy gatherings.

Importance & Scope

Cancer is the second leading cause of death worldwide. It’s crucial to remember that cancer is not one disease – it’s more than 200 cancer diseases involved. All different, unique diseases, which require different approaches for treatment. Treatments that work for some cancers don’t work for others and sometimes those treatments simply stop working. And only a global search for answers will help us get to grips with these disease. The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer or oncology. The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer or oncology.

Why to attend???

This is your best chance to reach the largest gathering of participants from the community, With members from around the world focused on learning about cancer prevention, and its advances;. Conduct presentations, distribute data, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent procedures, developments, and the newest updates in cancer prevention.

Cancer is a disease where abnormal cells divide uncontrollably and destroy body tissue. More than 100 types of cancer are exist, including breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer, and lymphoma. Signs vary depending on the type. Cure of Cancer may comprise chemotherapy, radiation, and/or surgery.

Cancer is a complex medical issue that requires a multidisciplinary approach. This approach is sweeping and ranges from well-being advancement to counteractive action and screening, diagnosis, treatment, restoration and palliative care.

Five Most common cancers in Dubai

• Cancer is the third foremost cause of death in the Emirate of Abu Dhabi. It is the third among nationals and the third among expatriates. It accounts for 16% of total deaths.
• There were about 427 deaths caused by cancer in 2015, 35% were nationals and 65% were expatriates.
•  44% of death were females and 56% were males
• The topmost five Leading causes of death among cancers in men (in order of frequency) are Lung, Colorectal, Liver, Leukemia and Pancreas.
• The topmost five Leading causes of death among cancers in Women (in order of frequency) are breast, Colorectal, Leukemia, Ovary, and Lung.       

    The Top Ten countries effected by cancer                                                                                                                                                                                                                                    

Target Audience    

Oncology Research 2018 welcomes the oncologists, hematologists, research scholars/Cancer Researchers, Nurses, Medical Colleges, immunologists, Cancer research Faculty, pathologists,  doctors/clinicians, industrial professionals, student delegates and cancer associations & societies from biomedical and healthcare sectors to be a part of it. 

Conference Highlights

Oncology

Cancer Biomarkers

Cancer Epidemiology

Cancer: Types and Stages

Cancer Immunology

Cancer Genomics

Diagnosis of cancer

Stem cell therapy in cancers

Breast cancer

Screening and prevention of cancer

Organ Specific Cancer

Radiation Oncology

Gynecologic Oncology

Pediatric Oncology

Neuro-oncology

Oncology Nursing

Cancer Pharmacology

Anticancer Drugs and surgery

Clinical Oncology and case reports

World’s Top Ten Cancer Drugs by 2020

As specified by the World Health Organization, around 8.2 million individuals bite the dust from disease consistently and it comprises an expected 13% of all passing around the world. It is likewise anticipated by the WHO that there will be a 70% expansion in new instances of tumor in the following two decades. Luckily, numerous pharma and biotech organizations are currently focused on this need.

A 2016 measurable report from Statista has shown the anticipated best 10 oncology drugs worldwide by 2020. The medications are positioned by income. The rundown is relied upon to be going by Revlimid, a disease tranquilize made by U.S.- based organization Celgene, determined to produce five of the main six malignancy sedates by 2020. Here are the best oncology solutions in detail.

Revlimid (Celgene) Generic Name: Lenalidomide Projected Sales in 2020: $10,110 Million, Imbruvica (AbbVie/J&J) Generic Name: Ibrutinib Projected Sales in 2020: $8,213 Million, Avastin (Roche) Generic Name: Bevacizumab Projected Sales in 2020: $ 6,733 Million, Opdivo (BMS) Generic Name: Nivolumab Projected Sales in 2020: $ 6,201 Million, Xtandi (Medivation & Astellas) Generic Name: Enzalutamide Projected Sales in 2020: $5,700 Million, Rituxan (Roche) Generic Name: Rituximab Projected Sales in 2020: $5,407 Million, Ibrance (Pfizer) Generic Name: Palbociclib Projected Sales in 2020: $4,722 Million, Perjeta (Roche) Generic Name: Pertuzumab Projected Sales in 2020: $4,669 Million, Herceptin (Roche) Generic Name: Trastuzumab Projected Sales in 2020: $4,573 Million, Keytruda (Merck) Generic Name: Pembrolizumab Projected Sales in 2020: $3,560 Million

Related societies:

American Association for Cancer Research, USA.

American Brain Tumor Association, USA.

American Cancer Society, USA.

American Society for Radiation Oncology, USA.

American Society of Clinical Oncology, USA.

European Association for Cancer Research, Europe.

Association for International Cancer Research AICR, UK.

Association of European Cancer Leagues, Europe.

European Oncology Nursing Society, Europe.

European Society for Medical Oncology, Europe.

European Society of Gynaecological Oncology, Europe.

European Society of Surgical Oncology, Europe.

Acoustic Neuroma Association of Australia, Australia.

Clinical Oncological Society of Australia, Australia.

Australian Society of Gynaecologic Oncologists, Australia.

Asian Society of Gynecologic Oncology, Asian.

Asian Society for Neuro-Oncology, Asian.

Saudi Cancer Society, Dubai, UAE.

Saudi oncology society and Saudi urology association, Dubai, UAE.

Saudi Arabia Cancer Organizations and Resources, Dubai, UAE.

Malaysian Oncology Society, Malaysia.

Malaysian Society of Paediatric Haematology and Oncology, Malaysia.

Top Universities

In Dubai

Murdoch University, Dubai

Heriot Watt University Dubai Campus

Modul University Dubai

Middlesex University Dubai

Hamdan Bin Mohammed  Smart University

Curtin University Dubai

University of South Wales Dubai

Emirates Aviation University

In UAE

Al Ghurair University (AGU)

University of Dubai (UD)

Zayed University

American University in Dubai (AUD)

British University in Dubai (BUiD)

American University in the Emirates (AUE)

Worldwide

University of Chicago, Chicago

University of Toronto, Canada

Washington University in St. Louis

Thomas Jefferson University

National University of Singapore (NUS), Singapore

Indianapolis University “La Sapienza” of Rome, Rome, Italy

University of Wisconsin, Madison-

University of Tokoyo, Japan

Guangxi Medical University, Nanning, China

University of Lyon, France

University Of Leeds

University Of Queensland,Australia

University of Arizona Cancer Center

University of Utah

Georgetown University Medical Center

University of Southampton

University of Pittsburgh

McMaster University

University Of Florida

Vanderbilt University School of Medicine

Wayne State University School of Medicine

The 19^th Euro Congress on Cancer Science and Therapy was organized on July 17-19, 2017 at Lisbon, Portugal. Cancer Science 2017 Congress has received a munificent response from all over the world. This has been conducted with the aim of promoting the developments of new perceptions and ideas for investigating the high level of knowledge reached by scientific community on Cancer Science and Therapy.

 The conference was organized around the theme “Defining an Evolved Approach towards Cancer Treatment”. The event imbedded a firm relation of future strategies in the field of Cancer Science with the scientific community.

This conference brought together Leading physicians, surgeons, Clinicians, Professors, Care Specialists, Students and other professionals in which many issues in Oncology field were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided an opportunity for networking.

The eminent personalities at the conference were

• Alvaro Macieira-Coelho, French National Institute of Health (INSERM), France
• Liane Deligdisch, Icahn School of Medicine at Mount Sinai, USA
• Sherry A Bradford, AccuTheranostics Inc., USA
• Isaura Meza, Cinvestav, Mexico

Conference series LLC takes its pleasure to thank all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners and all who supported the conference in every aspect for the magnificent presence at the venue.

 Conference Series is overwhelmed to announce the commencement of its Cancer Genomics Conference: New Era for Cancer Prevention on June 25^th-26^th, 2018 Dubai, UAE Cancer Genomics 2018 will be organized around the theme “Exploring ways to use genomics data to reveal new targets and therapies”. The conference is CME & CPD Accredited.